Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Kazuhiro Kurasawa, Ayae Tanaka, Tomoyuki Miyao, Wataru Fujii, Satoko Arai, Takayoshi Owada, Reika Maezawa, Masafumi Arima, Kei Ikeda
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
American thoracic society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
10.1164/ajrccm.165.2.ats01 · 2002
An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
10.1164/rccm.201308-1483st · 2013
Heterogeneity in unclassifiable interstitial lung disease: a systematic review and meta-analysis
10.1513/annalsats.201801-067oc · 2018
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
10.1183/16000617.0076-2018 · 2018
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
10.1183/09031936.00158507 · 2009
Clinical course of interstitial lung disease in patients with rheumatoid arthritis
10.1002/acr2.11736 · 2024
Phenotypic clusters predict outcomes in a longitudinal interstitial lung disease cohort
10.1016/j.chest.2017.09.026 · 2018
Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
10.1186/s12890-021-01428-3 · 2021
Cluster phenotypes in a non-idiopathic pulmonary fibrosis fibrotic interstitial lung diseases cohort in Singapore
10.21037/jtd-22-40 · 2022
Cluster features in fibrosing interstitial lung disease and associations with prognosis
10.1186/s12890-023-02735-7 · 2023
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation
10.1016/s2213-2600(24)00147-4 · 2024
Insights into interstitial lung disease pathogenesis
2025
Rheumatoid arthritis-associated interstitial lung disease: relevance of histopathologic and radiographic patterns
10.1378/chest.09-0444 · 2009
Rheumatoid arthritis-associated interstitial lung disease: manifestations and current concepts in pathogenesis and management
10.1183/16000617.0011-2021 · 2021
Two sides of the same coin? A review of similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease
10.1183/13993003.02533-2020 · 2021
BAL fluid concentrations of cytokines in patients with nonspecific interstitial pneumonia, usual interstitial pneumonia, collagen vascular disease-associated interstitial pneumonia, and sarcoidosis
2012
Polymyositis and dermatomyositis (first of two parts)
10.1056/nejm197502132920706 · 1975
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative
10.1002/art.27584 · 2010
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases
10.1034/j.1399-3003.1999.14b23.x · 1999
Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome in idiopathic pulmonary fibrosis
10.1159/000207617 · 2009
Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis
10.1177/170882679804600508 · 1998
Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis
10.1371/journal.pone.0116775 · 2015
Bronchoalveolar lavage fluid cellular characteristics, functional parameters, and cytokine and chemokine levels in interstitial lung diseases
10.1111/j.1365-3083.2008.02222.x · 2009
Bronchoalveolar lavage fluid cytokines and chemokines as predictors of outcome in systemic sclerosis-associated interstitial lung disease
10.1186/ar2766 · 2009
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-associated interstitial lung disease
10.1093/rheumatology/kez301 · 2020
Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis
10.1093/rheumatology/kead409 · 2024
IFN-γ–producing T-helper 17.1 cells are increased in sarcoidosis and more prevalent than T-helper type 1 cells
10.1164/rccm.201507-1499oc · 2016
Pulmonary sarcoidosis: a comprehensive review from past to present
10.1016/j.jaut.2023.103107 · 2024
Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study
2013
Progressive preclinical interstitial lung disease in rheumatoid arthritis
10.1001/archinternmed.2007.59 · 2008
Increased TNF-α secretion by alveolar macrophages from patients with rheumatoid arthritis
10.1164/ajrccm/143.3.593 · 1991
The IL-23–IL-17 axis in inflammatory arthritis
10.1038/nrrheum.2015.53 · 2015
GM-CSF in inflammation
10.1084/jem.20190945 · 2020
Role of GM-CSF in lung balance and disease
2023
GM-CSF in inflammation
10.1084/jem.20190945 · doi-reference
The IL-23–IL-17 axis in inflammatory arthritis
10.1038/nrrheum.2015.53 · doi-reference
Increased TNF-α secretion by alveolar macrophages from patients with rheumatoid arthritis
10.1164/ajrccm/143.3.593 · doi-reference
Progressive preclinical interstitial lung disease in rheumatoid arthritis
10.1001/archinternmed.2007.59 · doi-reference
Pulmonary sarcoidosis: a comprehensive review from past to present
10.1016/j.jaut.2023.103107 · doi-reference
IFN-γ–producing T-helper 17.1 cells are increased in sarcoidosis and more prevalent than T-helper type 1 cells
10.1164/rccm.201507-1499oc · doi-reference
Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis
10.1093/rheumatology/kead409 · doi-reference
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-associated interstitial lung disease
10.1093/rheumatology/kez301 · doi-reference
Bronchoalveolar lavage fluid cytokines and chemokines as predictors of outcome in systemic sclerosis-associated interstitial lung disease
10.1186/ar2766 · doi-reference
Bronchoalveolar lavage fluid cellular characteristics, functional parameters, and cytokine and chemokine levels in interstitial lung diseases
10.1111/j.1365-3083.2008.02222.x · doi-reference
Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis
10.1371/journal.pone.0116775 · doi-reference
Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis
10.1177/170882679804600508 · doi-reference
Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome in idiopathic pulmonary fibrosis
10.1159/000207617 · doi-reference
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases
10.1034/j.1399-3003.1999.14b23.x · doi-reference
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative
10.1002/art.27584 · doi-reference
Polymyositis and dermatomyositis (first of two parts)
10.1056/nejm197502132920706 · doi-reference
Two sides of the same coin? A review of similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease
10.1183/13993003.02533-2020 · doi-reference
Rheumatoid arthritis-associated interstitial lung disease: manifestations and current concepts in pathogenesis and management
10.1183/16000617.0011-2021 · doi-reference
Rheumatoid arthritis-associated interstitial lung disease: relevance of histopathologic and radiographic patterns
10.1378/chest.09-0444 · doi-reference
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation
10.1016/s2213-2600(24)00147-4 · doi-reference
Cluster features in fibrosing interstitial lung disease and associations with prognosis
10.1186/s12890-023-02735-7 · doi-reference
Cluster phenotypes in a non-idiopathic pulmonary fibrosis fibrotic interstitial lung diseases cohort in Singapore
10.21037/jtd-22-40 · doi-reference
Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
10.1186/s12890-021-01428-3 · doi-reference
Phenotypic clusters predict outcomes in a longitudinal interstitial lung disease cohort
10.1016/j.chest.2017.09.026 · doi-reference
Clinical course of interstitial lung disease in patients with rheumatoid arthritis
10.1002/acr2.11736 · doi-reference
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
10.1183/09031936.00158507 · doi-reference
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
10.1183/16000617.0076-2018 · doi-reference
Heterogeneity in unclassifiable interstitial lung disease: a systematic review and meta-analysis
10.1513/annalsats.201801-067oc · doi-reference
An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
10.1164/rccm.201308-1483st · doi-reference
American thoracic society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
10.1164/ajrccm.165.2.ats01 · doi-reference